XML 76 R70.htm IDEA: XBRL DOCUMENT v3.25.3
Accumulated other comprehensive income (loss) (Detail) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2025
Sep. 30, 2024
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Net other comprehensive income (loss) after tax $ (44) $ 673  
Foreign Currency Translation Adjustments [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Beginning Balance   (2,857) $ (2,384)
Other comprehensive income (loss) before reclassifications   509 (84)
Release of cumulative translation adjustments [1]   181  
Net other comprehensive income (loss) before tax   690 (84)
Corresponding income tax   45 (7)
Net other comprehensive income (loss) after tax   645 [2] (91) [3]
Ending Balance (2,212) (2,212) (2,475)
Derivative Financial Instruments [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Beginning Balance   (238) (266)
Other comprehensive income (loss) before reclassifications     0
Amounts reclassified to the statements of income   30 21
Net other comprehensive income (loss) before tax   30 21
Net other comprehensive income (loss) after tax   30 [2] 21 [3]
Ending Balance (208) (208) (245)
Benefit Plans [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Beginning Balance   (52) (46)
Other comprehensive income (loss) before reclassifications   0 1
Amounts reclassified to the statements of income   (2) (3)
Net other comprehensive income (loss) before tax   (2) (2)
Net other comprehensive income (loss) after tax   (2) [2] (2) [3]
Ending Balance (54) (54) (48)
AOCI Attributable to Parent [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Beginning Balance   (3,148) (2,697)
Other comprehensive income (loss) before reclassifications   509 (83)
Amounts reclassified to the statements of income   28 18
Release of cumulative translation adjustments [1]   181  
Net other comprehensive income (loss) before tax   718 (65)
Corresponding income tax   45 (7)
Net other comprehensive income (loss) after tax (44) 673 [2] (72) [3]
Ending Balance $ (2,475) $ (2,475) $ (2,769)
[1] In connection with the sale of Teva’s business venture in Japan.
[2] Amounts do not include a $27 million gain from foreign currency translation adjustments attributable to redeemable and non-redeemable non-controlling interests.
[3] Amounts do not include a $6 million loss from foreign currency translation adjustments attributable to non-controlling interests.